Profilo
Troy Hamilton formerly worked at Synergy Pharmaceuticals LLC, as Chief Executive Officer & Director from 2017 to 2019, Ellodi Pharmaceuticals, as Chief Executive Officer & Director from 2020 to 2024, and Shire Pharmaceuticals, Inc., as Vice President-Product Strategy.
Mr. Hamilton received his Masters Business Admin degree from St. Joseph's University and undergraduate degree from the University of the Sciences in Philadelphia.
Precedenti posizioni note di Troy Hamilton
| Società | Posizione | Fine |
|---|---|---|
Ellodi Pharmaceuticals
Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis | Amministratore Delegato | 01/11/2024 |
| SYNERGY PHARMACEUTICALS INC | Amministratore Delegato | 01/05/2019 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formazione di Troy Hamilton
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Sciences in Philadelphia
University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Ellodi Pharmaceuticals
Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis | Health Technology |
















